SLC2A10 and neoplasm: In addition, SLC2A10 expression had no significant correlation with tumor purity but had a significant positive correlation with infiltration levels in head and neck cancer (HNSC), kidney renal papillary cell carcinoma (KIRP), LUAD, LUSC, prostate adenocarcinoma (PRAD) and thyroid carcinoma (THCA) (Fig. 5B, D, F, G, H, J).